[en] Because of the importance of cytokines in the regulation of allergic inflammation, we investigated the effects of SCF, IL-3, IL-5 and GM-CSF on immunological histamine release from sensitized human lung fragments as well as human leukocytes. SCF (0.2-20 ng/ml) caused a concentration-related enhancement of anti-IgE (1/100) induced histamine release from lung fragments reaching maximally 64% at 20 ng/ml. In contrast, enhancement produced by IL-5, IL-3 and GM-CSF (0.2-20 ng/ml) was quite marginal and reached at best around 20% at the higher concentration, IL-5 being slightly more effective than IL-3 and GM-CSF. Further, SCF potentiated histamine release whatever the level of immunological control whereas potentiation by IL-5 primarily occurred when the amount of histamine release induced by the immunological control ranged between 5 and 10%. SCF acted synergistically with IL-5, producing a greater enhancement of histamine release than the sum of each cytokine used alone. Both SCF and, to a lesser extent, IL-5 potentiated anti-IgE-mediated histamine release regardless of passive sensitization of lung fragments. Unlike what was observed with lung fragments, IL-3, GM-CSF and to a lesser extent IL-5, were potent enhancing agents of anti-IgE (1/2,000)-induced histamine release from leukocytes. Maximal enhancement produced by IL-3 (20 ng/ml), GM-CSF (2 ng/ml) and IL-5 (20 ng/ml) reached 92%, 78% and 61%, respectively. By contrast, SCF (0.2-20 ng/ml) was ineffective on human leukocytes.(ABSTRACT TRUNCATED AT 250 WORDS)
Disciplines :
Cardiovascular & respiratory systems
Author, co-author :
Louis, Renaud ; Université de Liège - ULiège > Département des sciences cliniques > Pneumologie - Allergologie
Dowlati, A.
Weber, T.
Bury, Thierry ; Université de Liège - ULiège > Département des sciences de la motricité > Physiologie humaine et physiologie de l'effort physique
Corhay, Jean-Louis ; Université de Liège - ULiège > Pneumologie-Allergologie
Radermecker, Maurice ; Université de Liège - ULiège > Services généraux (Faculté de médecine) > Relations académiques et scientifiques (Médecine)
Language :
English
Title :
Modulation of Immunological Histamine Release from Human Lung Fragments by Stem Cell Factor, Il-3, Il-5 and Gm-Csf: Comparison with Human Leukocytes
Holgate ST: The mast cell and its function in allergic disease. Clin Exp Allergy 1991;21:53: 11-16.
Costa J, Burd P, Metcalfe D: Effects of cytokines on mast cells; in Kaliner MA, Metcalfe DD (eds); The Mast Cell in Health and Disease. New York. Marcel Dekker. 1992. pp 445-447.
Rottcm M; Kirschenbaum A. Metcalfe D: Early development of mast cells. Int Arch Allergy Appl Immunol 1991:94:104-109.
Kirschenbaum A, Goff J, Kessler S. Mican J. et al: Effects of IL-3 and stem cell factor on the appearance of human basophils and mast cells from CD34+ pluripotent progenitor cells. J Immunol 1992:148:772-777.
Robinson D, Hamid Q, Sun Ying, Tsicopoulos A, Barkand J, et al: Predominant Th2 like bron-choalveolar T lymphocyte population in atopic asthma. N Engl J Med 1992:326:298-304.
Hirai K, Morita Y, Misaki Y, et al: Modulation of human basophil histamine release by hemopoietic growth factors. J Immunol 1988:141: 3958-3964.
Bischoff S. Brunner T, de Week A, Dahindcn C: Interleukin 5 modifies histamine release and leukotriene generation by human basophils in response to diverse agonists. J Exp Med 1990; 172:1577-1582.
Radermcckcr M, Louis R, Leclerq M, Weber T, Corhay JL, Bury Th: Cytokine modulation of basophil histamine release in wasp venom allergy. Allergy 1994; in press.
Bischot TS, Dahinden C: C kit ligand: A unique potentiator of mediator release by human lung mast cells. J Exp Med 1992; 175:237-244.
De Paulis A, Ciccarelli A. Cirillo R, de Cres-ccnzo G. Colombo M. Marone G: Modulation of human lung mast ccll function by the C kit receptor ligand. Int Arch Allergy Immunol 1992;99:326-329.
Campbell A, Chanez P, Vignola A, Alba B, et al: Cytokine induced release of mast cell derived mediators from dispersed human lung mast cells (abstract). J Allergy Clin Immunol 1992; 89:244.
Peters S. Schulman E. Schleimcr R. McGlashan D. et al: Dispersed human lung mast cells: Pharmacologic aspects and comparison with human lung tissue fragments. Am Rev Resp Dis 1982; 126:1034-1039.
Tainsh K. Pearce F: Mast cell heterogeneity: Evidence that mast cells isolated from various connective tissue locations in the rat display markedly graded phenotypes. Int Arch Allergy Immunol 1992:98:26-34.
Church MK. Young K: The characteristics of inhibition of histamine release from human lung fragments by sodium cromoglyeate, salbutamol and chlorprobazine. Br J Pharmacol 1983:78: 671-679.
Casolaro V, Galeone D, Giacummo A, Sanduzzi A. Mclillo G, Marone G: Human basophil/mast cell releasability. V. Functional comparisons of cells obtained from peripheral blood, lung parenchyma and bronchoalveolar lavage in asthmatics. Am Rev Respir Dis 1989; 139:1375-1382.
Columbo M. Horowitz E, Botana L, McGlashan D, et al: The human recombinant C kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils. J Immunol 1992;149:599-608.
Spcrr W, Czerwenka K, Muller M, Semper H, et al: Specific activation of human mast cells by the ligand for C-kit: Comparison between lung, uterus and heart mast cells. Int Arch Allergy Immunol 1993;102:170-175.
Zsebo K, Williams D. Gcissler E, Broudy Y. el al: Stem cell factor (SCF) in encoded at the SI Locus of the mouse and is the ligand for the C kit thyrosine kinase receptor. Cell 1990;63: 213-224.
Hamid O, Azzawi M, Moqbel R, et al: Expression of mRNA for interleukin 5 in mucosal bronchial biopsies from asthma. J Clin Invest 1991;87:1541-1546.
Walker C, Bode E, Boer L, Hansel T, Blascr K, Virchov J: Allergic and nonallergic asthmatics have distinct patterns of T cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. Am Rev Resp Dis 1992;146:109-115.
Langley KE. Bennet LG, Wypych J, Yaneik SA. et al: Soluble stem cell factor in human serum. Blood 1993:81:656-660.
Valent P. Bcscmcr J, Sillaber C, Butterfield J. et al: Failure to detect 11.3 binding sites on human mast cells. J Immunol 1990;145:3432-3437.
Okayama Y, Church M: IL3 primes and evokes histamine release from human basophils but not mast cells. Int Arch Allergy Immunol 1992;99: 343 345.
Siraganian RP, Hook WA: Mechanism of histamine release by formyl-methionyl-containing peptides. J Immunol 1977;119:2078-2083.
Schwartz L: Heterogeneity of human mast cells; in Kalincr MA, Metcalfe DD (eds): The Mast Cell in Health and Disease. New York. Marcel Dekker. 1992, pp 219-236.
van Overveld F, Houben L, Schmitz F, Brujn-zecl P. et al: Mast cell heterogeneity in human lung tissue. Clin Sci 1989:77:297-304.
McDonalds S. Schleimer R, Sobotka A, Gillis S, Lichtenstein L: Recombinant IL3 induces histamine from human basophils. J Immunol 1989;142:3527-3532.
Pedersen M, Pirmin H, Bindslev-Jensen C, Bendtzen K. Norn S: Cytokine induced histamine release from basophils of AIDS patients. Allergy 1991;46:129-134.
Lopez A, Eglington J, Lyons A. Tapley P. et al: Human interleukin 3 inhibits the binding of gra-nulocyte-macrophage colony-stimulating factor and interleukin 5 to basophils and strongly enhances their functional activity. J Cell Physiol 1990:145:69-77.
Arai K, Yokota J, Watanabe S, Arai N, Miyajima A: The regulation of allergic response by cytokine receptor networks. ACI News 1992:4: 113-120.